Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RV5263A - WS0060 in Seborrheic Dermatitis
NCT07576023Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Feb 2025
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Randomised trial in seborrheic dermatitis (SD) (3 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Dandruff severity (Squire score) at 29 days. Started Feb 2025; status: completed.
02
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT07576023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07576023.